The digital revolution: technological innovations to enable automation in cell therapy manufacturing

Cell & Gene Therapy Insights 2022; 8(6), 661;

DOI: 10.18609/cgti.2022.099

Published: 13 July 2022
Poster
Bruce Greenwald, Sean Chang, Krish Roy

The manufacturing process is complex, labor-intensive, and requires many open manipulations. It is also difficult to synchronize different instruments and products to make the workflow traceable and compliant with regulatory requirements. To solve these issues, a closed modular system can help minimize contamination and maintain flexibility. Most importantly, automating the process can reduce labor and human error. It is in this third aspect that digitalization plays a particularly vital role.